San Francisco, CA, United States of America

Kathryn H Rosenbluth

USPTO Granted Patents = 37 

 

 

Average Co-Inventor Count = 5.1

ph-index = 15

Forward Citations = 542(Granted Patents)


Company Filing History:


Years Active: 2014-2025

Loading Chart...
Loading Chart...
Loading Chart...
37 patents (USPTO):Explore Patents

Title: Innovations by Kathryn H. Rosenbluth: Pioneering Cardiac Treatments

Introduction

Kathryn H. Rosenbluth, based in San Francisco, CA, is an accomplished inventor with an impressive portfolio of 33 patents. Her groundbreaking work in the field of medical technology, particularly related to cardiac dysfunction and peripheral nerve stimulation, has made significant impacts in healthcare.

Latest Patents

Among her latest patents are innovative systems and methods for treating cardiac dysfunction through peripheral nerve stimulation. These systems are tailored for the treatment and prevention of cardiac dysrhythmias and hypertension, focusing specifically on conditions like atrial fibrillation. Additionally, she has developed systems and methods for peripheral neuromodulation, where a wearable device with an electrically conductive skin interface stimulates underlying nerves from a transcutaneous surface stimulator. This versatile device accommodates various user sizes and targets critical nerves such as the peroneal, femoral, saphenous, and tibial nerves. The stimulation techniques may include burst stimulation and utilize inputs relating to autonomic nervous system activity.

Career Highlights

Throughout her career, Kathryn has contributed to notable organizations, including Cala Health, Inc. and the University of California. Her work has focused on bridging the gap between neuromodulation and its applications in cardiac health, showcasing her innovative spirit and dedication to enhancing medical treatment methodologies.

Collaborations

Kathryn has collaborated with several intelligent minds in her field, including Samuel Richard Hamner and Serena HanYing Wong. These partnerships have likely enriched her research and development process, promoting enhanced innovation and effectiveness in her work.

Conclusion

Kathryn H. Rosenbluth stands out as a prominent inventor, consistently pushing the boundaries of innovation in cardiac treatment technologies. Her contributions significantly enhance patient care, demonstrating the power of invention and collaboration in advancing healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…